Hello Folks,

Let's talk about EW - Edwards Life Sciences. I am accumlating the stock as it completes a large consolidation triangle well above it's bear market low of $60, down from it's all time high of $130. The stock can safely be accumulated up $100 and is still a bargain at that price. Here is a breakdown of the compaies business.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally.

It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases.

The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy.

In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation.

Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure.

The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

The company has a long history of performance and a deep pipline. While it's current metrics make it's value look rich the fact is this where knowing the long-term history of a companies earnings is invaluable. I can tell you they are writing down losses from investment that will boost future earnings far above their current levels. I strongly recommend this companies stock.

The average price target for EW is $84.50, which is 13.36% higher than the current price. The consensus rating is "Buy". These analyst are being overly cautious. The target is actually $100 easily as always with the timing dependent on overall market conditions. Nevertheless once this ctock does break $100 it will easily go to new all time highs long-term.

Thank you,

Isaac Rosen

(NOTE: This is NOT a recommendation to buy or sell any security as each individual should consider their circumstances and consult a professional advisor. This information is provided for educational and/or entertainment purposes only. Thank-you.)